Invesco Ltd. Lyra Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 22,654 shares of LYRA stock, worth $4,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,654

Previous 22,824 0.74%

Holding current value

$4,077

Previous $6,000 16.67%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.24 - $0.34 $40 - $57	-170 Reduced 0.74%	22,654 $5,000
Q2 2024 Aug 13, 2024	SELL	$0.26 - $6.25 $138,426 - $3.33 Million	-532,409 Reduced 95.89%	22,824 $6,000
Q1 2024 May 14, 2024	BUY	$4.55 - $6.53 $2.53 Million - $3.63 Million	555,233 New	555,233 $3.45 Million
Q4 2020 Feb 16, 2021	SELL	$9.28 - $13.88 $1.84 Million - $2.75 Million	-197,776 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$10.61 - $13.96 $32,954 - $43,359	-3,106 Reduced 1.55%	197,776 $2.21 Million
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $2.19 Million - $3.73 Million	200,882 New	200,882 $2.28 Million

Others Institutions Holding LYRA

# of Institutions

Shares Held

32.2M

Call Options Held

21.1K

Put Options Held

400

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $5.73M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account